NBTY Announces Preliminary Unaudited Sales Results for January 2005
15 Febbraio 2005 - 2:00PM
PR Newswire (US)
NBTY Announces Preliminary Unaudited Sales Results for January 2005
BOHEMIA, N.Y., Feb. 15 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading manufacturer and
marketer of nutritional supplements, today announced its
preliminary unaudited sales results for the month of January 2005.
For the month of January 2005, sales were $151 million compared to
$150 million for the month of January 2004. Sales results by
segment are as follows: SALES (Unaudited) FOR THE MONTH OF JANUARY
(In Millions) 2005 2004 % Change Wholesale/US Nutrition $65 $66 -2%
US Retail/Vitamin World $17 $20 -15% European Retail/ Holland &
Barrett/ GNC (UK) $50 $42 19% Direct Response/ Puritan's Pride $19
$22 -14% Total $151 $150 1% ABOUT NBTY NBTY is a leading vertically
integrated manufacturer and distributor of a broad line of
high-quality, value-priced nutritional supplements in the United
States and throughout the world. The Company markets approximately
1,500 products under several brands, including Nature's Bounty(R),
Vitamin World(R), Puritan's Pride(R), Holland & Barrett(R),
Rexall(R), Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R),
American Health(R), GNC (UK)(R) and DeTuinen(R). This release
contains certain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 with respect
to our financial condition, results of operations and business. All
of these forward-looking statements, which can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"plan," "project," "estimate," "intend," "may," "will," "should,"
"can," or "anticipates," or the negative thereof, or variations
thereon, or comparable terminology, or by discussions of strategy
which, although believed to be reasonable, are inherently
uncertain. Factors which may materially affect such forward-looking
statements include: (i) slow or negative growth in the nutritional
supplement industry; (ii) interruption of business or negative
impact on sales and earnings due to acts of war, terrorism,
bio-terrorism, civil unrest or disruption of mail service; (iii)
adverse publicity regarding nutritional supplements; (iv) inability
to retain customers of companies (or mailing lists) recently
acquired; (v) increased competition; (vi) increased costs; (vii)
loss or retirement of key members of management; (viii) increases
in the cost of borrowings and/or unavailability of additional debt
or equity capital; (ix) unavailability of, or inability to
consummate, advantageous acquisitions in the future, including
those that may be subject to bankruptcy approval or the inability
of NBTY to integrate acquisitions into the mainstream of its
business; (x) changes in general worldwide economic and political
conditions in the markets in which NBTY may compete from time to
time; (xi) the inability of NBTY to gain and/or hold market share
of its wholesale and/or retail customers anywhere in the world;
(xii) unavailability of electricity in certain geographical areas;
(xiii) the inability of NBTY to obtain and/or renew insurance
and/or the costs of the same; (xiv) exposure to and expense of
defending and resolving, product liability claims and other
litigation; (xv) the ability of NBTY to successfully implement its
business strategy; (xvi) the inability of NBTY to manage its
retail, wholesale, manufacturing and other operations efficiently;
(xvii) consumer acceptance of NBTY's products; (xviii) the
inability of NBTY to renew leases for its retail locations; (xix)
inability of NBTY's retail stores to attain or maintain
profitability; (xx) the absence of clinical trials for many of
NBTY's products; (xxi) sales and earnings volatility and/or trends
for the Company and its market segments; (xxii) the efficacy of
NBTY's Internet and on-line sales and marketing; (xxiii)
fluctuations in foreign currencies, including the British Pound;
(xxiv) import-export controls on sales to foreign countries; (xxv)
the inability of NBTY to secure favorable new sites for, and delays
in opening, new retail locations; (xxvi) introduction of new
federal, state, local or foreign legislation or regulation or
adverse determinations by regulators anywhere in the world
(including the banning of products) and more particularly proposed
Good Manufacturing Practices in the United States and the Food
Supplements Directive and Traditional Herbal Medicinal Products
Directive in Europe; (xxvii) the mix of NBTY's products and the
profit margins thereon; (xxviii) the availability and pricing of
raw materials; (xxix) risk factors discussed in NBTY's filings with
the U.S. Securities and Exchange Commission; (xxx) adverse effects
on NBTY as a result of increased gasoline prices and potentially
reduced traffic flow to NBTY's retail locations; (xxxi) adverse tax
determinations; and (xxxii) other factors beyond the Company's
control. Readers are cautioned not to place undue reliance on
forward-looking statements. NBTY cannot guarantee future results,
trends, events, levels of activity, performance or achievements.
NBTY does not undertake and specifically declines any obligation to
update, republish or revise forward- looking statements to reflect
events or circumstances after the date hereof or to reflect the
occurrences of unanticipated events. Consequently, such forward
looking statements should be regarded solely as NBTY's current
plans, estimates and beliefs. DATASOURCE: NBTY, Inc. CONTACT:
Harvey Kamil, President & Chief Financial Officer, of NBTY,
Inc., +1-631-200-2020; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, Web site: http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024